Nephrocare Health Services Ltd
Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets.[1]
- Market Cap ₹ 4,596 Cr.
- Current Price ₹ 488
- High / Low ₹ /
- Stock P/E 134
- Book Value ₹
- Dividend Yield %
- ROCE 9.56 %
- ROE 7.29 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company's working capital requirements have reduced from 78.7 days to 61.9 days
Cons
- Company has a low return on equity of 1.79% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 317 | 386 | 436 | 544 | |
| 299 | 348 | 384 | 449 | |
| Operating Profit | 18 | 38 | 52 | 95 |
| OPM % | 6% | 10% | 12% | 17% |
| 4 | 5 | 8 | 16 | |
| Interest | 10 | 15 | 17 | 14 |
| Depreciation | 39 | 41 | 43 | 51 |
| Profit before tax | -28 | -13 | 0 | 45 |
| Tax % | -22% | 20% | -1,668% | 25% |
| -22 | -15 | 4 | 34 | |
| EPS in Rs | -110.19 | -77.01 | 18.76 | 164.24 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 53% |
| TTM: | 767% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 2% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 |
| Reserves | 407 | 392 | 399 | 537 |
| 119 | 200 | 182 | 127 | |
| 45 | 54 | 82 | 92 | |
| Total Liabilities | 572 | 647 | 665 | 757 |
| 167 | 169 | 219 | 234 | |
| CWIP | 2 | 3 | 1 | 4 |
| Investments | 110 | 148 | 149 | 212 |
| 293 | 328 | 297 | 306 | |
| Total Assets | 572 | 647 | 665 | 757 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 12 | 11 | 57 | 80 | |
| -167 | -75 | -23 | -104 | |
| 147 | 63 | -36 | 26 | |
| Net Cash Flow | -8 | -0 | -1 | 2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 106 | 122 | 116 | 130 |
| Inventory Days | 50 | 61 | 51 | 43 |
| Days Payable | 52 | 40 | 108 | 150 |
| Cash Conversion Cycle | 104 | 143 | 59 | 23 |
| Working Capital Days | 48 | 116 | 58 | 62 |
| ROCE % | 0% | 3% | 10% |
Business Profile[1]
Nephrocare Health Services Limited (NHSL) is India’s largest dialysis-care provider offering a full spectrum of renal-care services haemodialysis, peritoneal dialysis, home haemodialysis, dialysis-on-call, dialysis-on-wheels, pharmacy support, diagnostics, and wellness management. It operates through captive hospital-based clinics, standalone centres, and large Public-Private Partnership (PPP) units.